Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators

被引:8
|
作者
Wang, Mei [1 ]
Zhang, Jian [1 ]
Dou, Yutong [2 ,3 ]
Liang, Minghui [1 ]
Xie, Yong [4 ]
Xue, Peng [5 ]
Liu, Linyue [1 ]
Li, Chuanju [6 ]
Wang, Yuanze [7 ]
Tao, Feiyan [5 ]
Zhang, Xiaohui [8 ,9 ,10 ]
Hu, Huili [8 ,9 ,10 ]
Feng, Kairui [1 ]
Zhang, Lei [1 ]
Wu, Zhuanchang [2 ,3 ]
Chen, Yunfu [4 ]
Zhan, Peng [11 ]
Jia, Haiyong [1 ]
机构
[1] Weifang Med Univ, Sch Pharm, Weifang 261053, Shandong, Peoples R China
[2] Shandong Univ, Key Lab Expt Teratol, Key Lab Infect & Immun Shandong Prov, Minist Educ, Jinan 250012, Shandong, Peoples R China
[3] Shandong Univ, Qilu Hosp, Cheeloo Med Coll, Sch Basic Med Sci,Dept Immunol, Jinan 250012, Shandong, Peoples R China
[4] Sunshine Lake Pharm Co Ltd, State Key Lab Antiinfect Drug Dev 2015DQ780357, Dongguan 523871, Peoples R China
[5] Weifang Med Univ, Sch Publ Hlth, Weifang 261053, Shandong, Peoples R China
[6] Jining Med Univ, Dept Rehabil, Affiliated Hosp, Jining 272000, Shandong, Peoples R China
[7] Guangzhou Lab, Guangzhou Int Bio Isl, Guangzhou 510000, Guangdong, Peoples R China
[8] Shandong Univ, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Peoples R China
[9] Shandong Univ, Qilu Hosp, Cheeloo Med Coll, Sch Basic Med Sci,Dept Genet, Jinan 250012, Peoples R China
[10] Shandong Univ, Cheeloo Coll Med, Res Ctr Stem Cell & Regenerat Med, Sch Basic Med Sci,Dept Syst Biomed, Jinan 250012, Peoples R China
[11] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
HEPATITIS-B-VIRUS; INHIBITORS; REPLICATION; DISCOVERY;
D O I
10.1021/acs.jmedchem.3c01022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hepatitis B virus (HBV) capsid assembly modulators (CAMs) represent a promising therapeutic approach for the treatment of HBV infection. In this study, we designed and synthesized five series of benzamide derivatives based on a multisite-binding strategy at the tolerant region and diversity modification in the solvent-exposed region. Among them, thioureidobenzamide compound 17i exhibited significantly increased anti-HBV activity in HepAD38 (EC50 = 0.012 mu M) and HBV-infected HLCZ01 cells (EC50 = 0.033 mu M). Moreover, 17i displayed a better inhibitory effect on the assembly of HBV capsid protein compared with NVR 3-778 and a inhibitory effect similar to the clinical drug GLS4. In addition, 17i showed moderate metabolic stability in human microsomes, had excellent oral bioavailability in Sprague-Dawley (SD) rats, and inhibited HBV replication in the HBV carrier mice model, which could be considered as a promising candidate drug for further development.
引用
收藏
页码:13968 / 13990
页数:23
相关论文
共 50 条
  • [41] Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
    Zhang, Xujie
    Sun, Lin
    Xu, Shujing
    Shao, Xiaoyu
    Li, Ziyi
    Ding, Dang
    Jiang, Xiangyi
    Zhao, Shujie
    Cocklin, Simon
    De Clercq, Erik
    Pannecouque, Christophe
    Dick, Alexej
    Liu, Xinyong
    Zhan, Peng
    MOLECULES, 2022, 27 (21):
  • [42] Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators
    Detta, Elena
    Corcuera, Angelica
    Urban, Andreas
    Goldner, Thomas
    Bonsmann, Susanne
    Engel, Florian
    May, Marina M.
    Buschmann, Helmut
    Fianchini, Mauro
    Alza, Esther
    Pericas, Miquel A.
    Pushkarev, Pavel A.
    Varenyk, Anatolii O.
    Yakovyuk, Taras Y.
    Homon, Anton A.
    Sokoliuk, Pavlo A.
    Smaliy, Radomyr
    Donald, Alastair
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 93
  • [43] Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors
    Boucle, Sebastien
    Lu, Xiao
    Bassit, Leda
    Ozturk, Tugba
    Russell, Olivia Inger
    Amblard, Franck
    Coats, Steven J.
    Schinazi, Raymond F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (04) : 904 - 910
  • [44] The SAR-based development of small molecular HBV capsid assembly modulators
    Yunwen Wang
    Shendan Wang
    Xuefen Tao
    Yuan Wang
    Yuxuan Wu
    Na Chen
    Chenxian Hu
    Hao Wang
    Shuang Yu
    Rong Sheng
    Medicinal Chemistry Research, 2022, 31 : 1414 - 1430
  • [45] The SAR-based development of small molecular HBV capsid assembly modulators
    Wang, Yunwen
    Wang, Shendan
    Tao, Xuefen
    Wang, Yuan
    Wu, Yuxuan
    Chen, Na
    Hu, Chenxian
    Wang, Hao
    Yu, Shuang
    Sheng, Rong
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (09) : 1414 - 1430
  • [46] Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection
    Cole, Andrew G.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 131 - 137
  • [47] Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles
    Vanrusselt, Hannah
    Kum, Dieudonne Buh
    Taverniti, Valerio
    Liu, Cheng
    Acosta Sanchez, Abel
    Corthout, Nikky
    Munck, Sebastian
    Baumert, Thomas F.
    Beigelman, Leonid
    Blatt, Lawrence M.
    Symons, Julian A.
    Deval, Jerome
    Raboisson, Pierre
    Verrier, Eloi R.
    Jekle, Andreas
    Vendeville, Sandrine
    Debing, Yannick
    JOURNAL OF VIROLOGY, 2023, 97 (10)
  • [48] Design, synthesis and biological evaluation of biaryl amide derivatives as modulators of multi-drug resistance
    Peng, Ying-Yuan
    Shi, Zhi-Xian
    Yu, Min
    Karam, Sami
    Chen, Zhi-Long
    Wang, Yang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 282
  • [49] Design, synthesis, and evaluation of novel phenothiazine derivatives as modulators in chloroquine resistance malaria.
    Guan, J
    Gerena, L
    Kyle, DE
    Milhous, WK
    Lin, AJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U553 - U553
  • [50] Design, Synthesis and biological evaluation of the novel antitumor agent aurone derivatives
    Guo, QianNan
    Iv, Lei
    Zhou, Yao
    Yu, Peng
    Teng, Yuou
    ADVANCES IN CHEMICAL ENGINEERING III, PTS 1-4, 2013, 781-784 : 1235 - +